'Two US congressional committees have accused the Food and Drug Administration of inappropriately collaborating with Biogen before approving the company’s Alzheimer’s drug.'

#FDA #Alzheimer #Biogen #DrugDevelopment

https://www.ft.com/content/5389750b-71b0-4fe6-9793-feb6f64712e1